Jiri Drahota

5PUBLICATIONS
31CO-AUTHORS
Nanotoxicology, health and safetyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

|Dec 23, 2025
From sunlight to MS fight: impact of vitamin D levels on multiple sclerosis activity.

Marta Vachova, Dominika Stastna, Aneta Mazouchova

|Jul 26, 2024
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry.

Pavel Potuznik, Jiri Drahota, Dana Horakova

|Nov 28, 2023
COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark.

Dominika Stastna, Frederik Elberling, Luigi Pontieri

|Feb 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers.

Lars Forsberg, Tim Spelman, Pernilla Klyve

Pageof 1

Frequent Collaborators

3 joint publications

Dana Horakova

3 joint publications

Dominika Stastna

2 joint publications

Luigi Pontieri

2 joint publications

Marta Vachova